These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35648000)

  • 1. Current estimates of the economic burden of blindness and visual impairment in India: A cost of illness study.
    Mannava S; Borah RR; Shamanna BR
    Indian J Ophthalmol; 2022 Jun; 70(6):2141-2145. PubMed ID: 35648000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic and social costs of visual impairment and blindness in India.
    Wong B; Singh K; Khanna RK; Ravilla T; Shalinder S; Sil A; Dole K; Jain E; Chase H
    Indian J Ophthalmol; 2022 Oct; 70(10):3470-3475. PubMed ID: 36190029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Simple Method for Estimating the Economic Cost of Productivity Loss Due to Blindness and Moderate to Severe Visual Impairment.
    Eckert KA; Carter MJ; Lansingh VC; Wilson DA; Furtado JM; Frick KD; Resnikoff S
    Ophthalmic Epidemiol; 2015; 22(5):349-55. PubMed ID: 26395661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India.
    Redding S; Anderson R; Raman R; Sivaprasad S; Wittenberg R;
    BMJ Open; 2023 Jun; 13(6):e063390. PubMed ID: 37355259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of blindness in India.
    Shamanna BR; Dandona L; Rao GN
    Indian J Ophthalmol; 1998 Sep; 46(3):169-72. PubMed ID: 10085631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Economic Impact of Blindness in Europe.
    Chakravarthy U; Biundo E; Saka RO; Fasser C; Bourne R; Little JA
    Ophthalmic Epidemiol; 2017 Aug; 24(4):239-247. PubMed ID: 28665742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.
    ;
    Lancet Glob Health; 2021 Feb; 9(2):e130-e143. PubMed ID: 33275950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thirty Year Projected Magnitude (to 2050) of Near and Distance Vision Impairment and the Economic Impact if Existing Solutions are Implemented Globally.
    Bastawrous A; Suni AV
    Ophthalmic Epidemiol; 2020 Apr; 27(2):115-120. PubMed ID: 31810404
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost of vision loss in Canada. 2. Results.
    Cruess AF; Gordon KD; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):315-8. PubMed ID: 21816249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.
    ;
    Lancet Glob Health; 2021 Feb; 9(2):e144-e160. PubMed ID: 33275949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magnitude and cost of global blindness: an increasing problem that can be alleviated.
    Frick KD; Foster A
    Am J Ophthalmol; 2003 Apr; 135(4):471-6. PubMed ID: 12654362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Economic Burden of Vision Loss and Blindness in the United States.
    Rein DB; Wittenborn JS; Zhang P; Sublett F; Lamuda PA; Lundeen EA; Saaddine J
    Ophthalmology; 2022 Apr; 129(4):369-378. PubMed ID: 34560128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
    Chuvarayan Y; Finger RP; Köberlein-Neu J
    Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global economic productivity losses from vision impairment and blindness.
    Marques AP; Ramke J; Cairns J; Butt T; Zhang JH; Muirhead D; Jones I; Tong BAMA; Swenor BK; Faal H; Bourne RRA; Frick KD; Burton MJ
    EClinicalMedicine; 2021 May; 35():100852. PubMed ID: 33997744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude and causes of blindness and low vision in Anambra State of Nigeria (results of 1992 point prevalence survey).
    Ezepue UF
    Public Health; 1997 Sep; 111(5):305-9. PubMed ID: 9308379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of blindness in India from 2000 through 2020: implications for the blindness control policy.
    Dandona L; Dandona R; John RK
    Natl Med J India; 2001; 14(6):327-34. PubMed ID: 11804362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey.
    Thulasiraj RD; Nirmalan PK; Ramakrishnan R; Krishnadas R; Manimekalai TK; Baburajan NP; Katz J; Tielsch JM; Robin AL
    Ophthalmology; 2003 Aug; 110(8):1491-8. PubMed ID: 12917162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of a Simple Model to Calculate the Annual Global Productivity Loss Due to Blindness and Moderate and Severe Vision Impairment.
    Eckert KA; Lansingh VC; Carter MJ; Frick KD
    Ophthalmic Epidemiol; 2022 May; ():1-9. PubMed ID: 35610969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.